KCM
TEVA icon

Kempner Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Kempner Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-77,210
Closed -$713K – 50
2019
Q2 		$713K Hold
77,210
– – 0.47% 40
2019
Q1 		$1.21M Sell
77,210
-21
-0% -$370 0.8% 37
2018
Q4 		$1.19M Sell
77,231
-157
-0.2% -$3.22K 0.82% 35
2018
Q3 		$1.67M Sell
77,388
-41
-0.1% -$952 1.07% 31
2018
Q2 		$1.88M Sell
77,429
-27
-0% -$551 1.24% 31
2018
Q1 		$1.32M Buy
77,456
+272
+0.4% +$5.31K 0.9% 32
2017
Q4 		$1.46M Sell
77,184
-131,773
-63% -$1.98M 0.91% 32
2017
Q3 		$3.68M Buy
208,957
+5,275
+3% +$119K 2.42% 17
2017
Q2 		$6.77M Buy
203,682
+3,632
+2% +$112K 4.45% 6
2017
Q1 		$6.42M Buy
200,050
+31,860
+19% +$1.09M 4.28% 7
2016
Q4 		$6.1M Buy
168,190
+89,245
+113% +$3.56M 4.43% 4
2016
Q3 		$3.63M Sell
78,945
-2,800
-3% -$146K 2.5% 18
2016
Q2 		$4.11M Hold
81,745
– – 2.64% 18
2016
Q1 		$4.37M Buy
81,745
+27,155
+50% +$1.59M 2.63% 17
2015
Q4 		$3.58M Buy
54,590
+13,125
+32% +$811K 2.1% 22
2015
Q3 		$2.34M Sell
41,465
-27,680
-40% -$1.79M 1.33% 35
2015
Q2 		$4.09M Buy
69,145
+11,200
+19% +$691K 2.13% 20
2015
Q1 		$3.61M Sell
57,945
-46,510
-45% -$2.7M 2.29% 16
2014
Q4 		$6.01M Sell
104,455
-34,880
-25% -$1.94M 2.7% 12
2014
Q3 		$7.49M Sell
139,335
-6,600
-5% -$350K 3.19% 9
2014
Q2 		$7.65M Sell
145,935
-36,430
-20% -$1.86M 3.03% 12
2014
Q1 		$9.64M Sell
182,365
-46,840
-20% -$2.16M 3.91% 6
2013
Q4 		$9.19M Sell
229,205
-12,500
-5% -$492K 3.9% 7
2013
Q3 		$9.13M Hold
241,705
– – 3.71% 8
2013
Q2 		$9.47M Buy
+241,705
New +$9.41M 3.97% 6

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Kempner Capital Management's TEVA Position: Q3 2019 in Review

Kempner Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 77,210 shares — an estimated $713K sold.

Kempner Capital Management first reported a position in TEVA in Q2 2013 and held it in 25 quarters. The position peaked at $9.64M in Q1 2014. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Kempner Capital Management reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Kempner Capital Management sold 77,210 Teva Pharmaceuticals shares in Q3 2019, an estimated $713K.
  • Kempner Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 25 quarters.
  • Kempner Capital Management's Teva Pharmaceuticals position peaked at $9.64M in Q1 2014.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Kempner Capital Management's 13F filing for Q3 2019, filed 4 Oct 2019.